查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
血酮儀市場-增長、趨勢、COVID-19 影響和預測 (2023-2028)
市場調查報告書
商品編碼
1190112

血酮儀市場-增長、趨勢、COVID-19 影響和預測 (2023-2028)

Blood Ketone Meter Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計血酮儀市場在預測期內（2022 年至 2027 年）的複合年增長率為 6.7%。

預計 COVID-19 大流行將對市場產生重大影響。 糖尿病發病率的增加和糖尿病酮症酸中毒病例的增加預計將推動市場增長。 根據美國糖尿病協會的說法，糖尿病患者感染 COVID-19 後更容易出現並發症。 根據國際糖尿病聯合會 (IDF) 2019 年的一份報告，糖尿病影響了全球約 4.63 億 20 至 79 歲的成年人，到 2045 年將達到 7 億。據預測，

由於設備的技術進步，預計該市場將顯著增長。 比如Foracare的血糖血酮儀“FORA 6 Gtel”就具備了3G/4G連接功能。 FORA 6 測試條採用 5 電極設計和金條，可確保高精度和準確度。 可測血糖、血細胞比容、血紅蛋白、B酮、總膽固醇、尿酸6項。 此外，無需與智能手機配對，即可輕鬆將數據傳輸至遠程健康管理系統。 由於這些因素，預計該市場將在預測期內擴大。

主要市場趨勢

血酮儀領域有望佔據主要市場份額

血酮儀部門認為，這些設備可能有助於及早發現酮體產生，警告即將發生的酮症酸中毒，並最終減少糖尿病酮症酸中毒的並發症。因此，它已經佔據了很大的市場份額。 糖尿病酮症酸中毒和糖尿病患病率上升是推動市場增長的主要因素之一。 此外，世界上老年人和肥胖人口的增加預計將推動市場增長。 根據世界衛生組織 (WHO) 的數據，到 2050 年，世界上 60 歲及以上的人口將達到 20 億。 根據國際糖尿病聯合會於 2021 年 9 月更新的糖尿病事實與數據，全球約有 5.37 億成年人患有糖尿病。 預計到 2030 年將增加到 6.43 億，到 2045 年將增加到 7.83 億。 這可能會增加對血酮體市場的需求，因為這些設備可以測量血液中的酮體水平。

由於夥伴關係和協作的增加，該領域有望實現顯著增長。 例如，2020 年 2 月，全球糖尿病非營利組織 Beyond Type 宣布與全國學校護士協會建立新的合作夥伴關係，以提高人們對 1 型糖尿病 (T1D) 警告信號的認識。 這一新的合作夥伴關係將向全美數千名學校護士分發教育材料。 提高認識計劃將使有糖尿病風險的人更容易參與以證據為基礎的生活方式改變計劃，以降低他們患糖尿病的風險，這可能會在預測期內推動市場。 市場進入者獲得了 CE（Conformite Europeenne）和 FDA（食品和藥物管理局）先進血酮儀的批准，獲得了更大的市場份額，尖端技術產品幫助人們輕鬆追蹤他們的血酮水平。 例如，Abbott 的 FreeStyle Optium Neo 是一款超薄輕便的血糖儀，可放入您的口袋，並在一米內提供準確的血糖和酮讀數。 因此，預計在預測期內，全球範圍內產品批准的增加將提振市場。

預計在預測期內北美將佔據重要的市場份額

北美主導著血酮儀市場。 由於該地區主要參與者的各種合併、合作和收購，預計在預測期內將保持這種狀態。 2019 年 3 月，血糖和酮體測試製造商 Keto Mojo 與個人健康數據分析軟件公司 Heads Up Health 合作，開發了可與酮測量儀同步的 Keto-Mojo App。 這種集成將使 Keto Mojo 用戶能夠跟蹤他們的健康狀況。 2020 年 3 月，EKF Diagnostics 宣佈在美國市場推出其 FDA CLIA 豁免 B 酮和葡萄糖 POC 分析儀 STAT-Site WB Analyzer。 STAT-Site WB 在糖尿病管理中可兼作專業全血 B 酮和血糖儀。

醫療設施中質量更高的基礎設施和整個地區血酮監測器的更多采用，尤其是在 COVID-19 流行期間，預計將有助於北美市場的增長。 據推測，政府促進葡萄糖和酮體監測的舉措將顯著推動市場。 根據美國疾病控制與預防中心於 2021 年 8 月更新的國家糖尿病預防計劃，美國政府正在努力製定國家糖尿病預防計劃等意識計劃，以解決前驅糖尿病和 2 型糖尿病日益增加的負擔。 該倡議在公共和私人機構之間建立了夥伴關係，以提供具有成本效益的干預措施和循證治療，以幫助在美國預防 2 型糖尿病。

預計糖尿病患者的增加將增加對測量酮體水平的血酮儀的需求。 例如，根據疾病預防控制中心的數據，美國約有 10.5% 的人口患有糖尿病，2020 年美國約有 2690 萬人被診斷出患有糖尿病。 據美國糖尿病協會稱，2018 年將有約 21 萬名 20 歲以下的美國人被診斷出患有糖尿病。 年輕人中糖尿病患者的這種增加預計會產生對血酮儀的需求。

競爭格局

血酮儀市場相當分散，有一些主要和較小的參與者。 市場參與者專注於研發，為市場開發技術先進的產品。 市場上的主要參與者包括 Abbott Laboratories、Nova Biomedical、Nipro Corporation、TaiDoc Technology Corporation、ForaCare Inc.、A. Menarini Diagnostics Srl。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 糖尿病患病率上升
    • 增加產品發布和批准
  • 市場製約因素
    • 產品召回率增加
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分

  • 產品類型
    • 血酮計
    • 血糖/酮計
    • 消耗品
  • 用法
    • 人體
    • 對於動物
  • 最終用戶
    • 醫院和診所
    • 診斷中心
    • 其他最終用戶
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 世界其他地區

第六章競爭格局

  • 公司簡介
    • Abbott Laboratories
    • Nova Biomedical
    • Nipro Corporation
    • TaiDoc Technology Corporation
    • ForaCare Inc.
    • A. Menarini Diagnostics Srl
    • ACON Laboratories Inc.
    • APEX Biotechnology Corporation
    • EKF Diagnostics
    • GlucoRx Ltd
    • MED TRUST
    • KETO-MOJO
    • PortaScience Inc.

第7章 市場機會今後動向

簡介目錄
Product Code: 72500

The blood ketone meter market is projected to register a CAGR of 6.7% during the forecast period (2022-2027).

The COVID-19 pandemic is expected to have a significant impact on the market. An increase in the incidence of diabetes and rising cases of diabetic ketoacidosis are expected to drive market growth. According to the American Diabetes Association, people with diabetes are more likely to have worse complications if affected by COVID-19. According to the International Diabetes Federation's (IDF) report published in 2019, globally, around 463 million adults aged 20 to 79 years were suffering from diabetes, and it is projected to reach 700 million by 2045.

This market is expected to witness significant growth due to the technological advancements in the devices. For example, the blood glucose and ketone testing meter by Foracare Inc., FORA 6 Gtel, comes with 3G/4G connectivity. With 5-Electrode Technology and strips made with gold, FORA 6 test strips guarantee high accuracy and precision. They measure six parameters: glucose, hematocrit, hemoglobin, B-ketone, total cholesterol, and uric acid in the blood. They can effortlessly transfer data to a TeleHealth System without pairing it with a smartphone. Hence, the market is expected to propel during the forecast period due to the factors mentioned above.

Key Market Trends

The Blood Ketone Monitoring Segment is Expected to Account for a Major Market Share

The blood ketone monitoring segment captured a significant share of the market as these devices help in the early identification of the production of ketones and may also warn of impending ketoacidosis, which may ultimately reduce the complications of diabetic ketoacidosis. The rising prevalence of diabetic ketoacidosis and diabetes is among the major factors augmenting the market growth. The rise in the geriatric and obese population worldwide is expected to boost the growth of the market. As per the World Health Organization (WHO), the global population aged 60 years and above is likely to reach 2 billion by 2050. According to Diabetes Facts & Figures updated in the International Diabetes Federation in September 2021, approximately 537 million adults were living with diabetes worldwide. It is expected to rise to 643 million by 2030 and 783 million by 2045. This may increase the demand in the blood ketone meter market as these devices measure the level of ketones in the blood.

This segment is expected to witness significant growth due to increasing partnerships and collaborations. For instance, in February 2020, global diabetes non-profit Beyond Type 1 announced a new partnership with the National Association of School Nurses to create awareness about Type 1 diabetes (T1D) warning signs. With this new partnership, awareness materials will be circulated to thousands of school nurses nationally in United States. Awareness programs make it easier for people at risk for diabetes to participate in evidence-based lifestyle change programs to reduce their risk of diabetes, which may drive the market during the forecast period. Market participants are getting Conformite Europeenne (CE) and Food and Drug Administration (FDA) approvals for their advanced blood ketone meters, which will help capture a larger market share and help people track their blood ketone levels easily with updated technological products. For instance, Abbots's FreeStyle Optium Neo, an ultra-thin, lightweight meter that fits in a pocket, can test both blood glucose and ketone readings in the same meter with accurate results. Thus, product approvals worldwide are likely to boost the market during the forecast period.

North America is Expected to Hold a Significant Market Share During the Forecast Period

North America dominates the blood ketone meter market. It is expected to do so during the forecast period due to various mergers, partnerships, and acquisitions by key players in the region. In March 2019, Keto Mojo, a blood glucose and ketone testing manufacturing company, entered a partnership with Heads Up Health, a software data analytics company for personal health, to develop Keto-Mojo App, which can be synchronized with the ketone meter. This integration will help Keto Mojo users constantly check their health profiles. In March 2020, EKF Diagnostics announced the launch of United States Food and Drug Administration Clinical Laboratory Improvement Amendments (FDA CLIA) waived B-ketone and glucose POC analyzer STAT-Site WB Analyzer in the US market. The STAT-Site WB is a dual-use whole blood B-ketone and glucose meter for professional use in the management of diabetes.

Better quality infrastructure in healthcare facilities and the high adoption of blood ketone meters, especially during the COVID-19 pandemic, across the region are projected to contribute to the market growth in North America. Government initiatives to promote glucose and ketone monitoring are estimated to drive the market significantly. According to the National Diabetes Prevention Program updated in the Centers for Disease Control in August 2021, the US government raised awareness programs like The National Diabetes Prevention Program to address the increasing burden of pre-diabetes and type 2 diabetes. This effort created partnerships between public and private organizations to offer cost-effective interventions and evidence-based treatments that help prevent type 2 diabetes across United States.

The increasing prevalence of diabetes is anticipated to create demand for blood ketone meters for measuring ketone levels. For instance, according to the CDC, around 10.5% of the US population was suffering from diabetes, and approximately 26.9 million people in United States were diagnosed with diabetes in 2020. As per the American Diabetes Association, in 2018, about 210,000 Americans under the age of 20 years were projected to have been diagnosed with diabetes. This rise in diabetes among the youth is expected to create the demand for blood ketone meters.

Competitive Landscape

The blood ketone meter market is moderately fragmented, with a few major players and small players. The market players are focusing on research and development to develop technologically advanced products in the market. Some of the major players in the market are Abbott Laboratories, Nova Biomedical, Nipro Corporation, TaiDoc Technology Corporation, ForaCare Inc., and A. Menarini Diagnostics Srl.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Diabetes
    • 4.2.2 Increasing Product Launches and Approvals
  • 4.3 Market Restraints
    • 4.3.1 Rising Instances of Product Recalls
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Product Type
    • 5.1.1 Blood Ketone Monitoring
    • 5.1.2 Blood Glucose and Ketone Monitoring
    • 5.1.3 Consumables
  • 5.2 Application
    • 5.2.1 Human
    • 5.2.2 Veterinary
  • 5.3 End User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.2 Europe
    • 5.4.3 Asia-Pacific
    • 5.4.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Nova Biomedical
    • 6.1.3 Nipro Corporation
    • 6.1.4 TaiDoc Technology Corporation
    • 6.1.5 ForaCare Inc.
    • 6.1.6 A. Menarini Diagnostics Srl
    • 6.1.7 ACON Laboratories Inc.
    • 6.1.8 APEX Biotechnology Corporation
    • 6.1.9 EKF Diagnostics
    • 6.1.10 GlucoRx Ltd
    • 6.1.11 MED TRUST
    • 6.1.12 KETO-MOJO
    • 6.1.13 PortaScience Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS